Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors - Tsuchiya, Nobuhiro; Hosono, Ako; Yoshikawa, Toshiaki; Shoda, Kayoko; Nosaka, Kazuto; Shimomura, Manami; Hara, Junichi; Nitani, Chika; Manabe, Atsushi; Yoshihara, Hiroki; Hosoya, Yosuke; Kaneda, Hide; et al. (Oncoimmunology, 2018)
Keywords: CTL; glypican-3 (GPC3); Original Research; pediatric solid tumors; peptide vaccine; phase I; pediatric solid tumors; CTL; phase I; peptide vaccine; glypican-3 (GPC3)